First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori Stephan Timm, Marco Sailer, Karl–hermann.

Slides:

Advertisements

Similar presentations

Se cond Cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and.

Advertisements

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.

Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.

Volume 117, Issue 6, Pages (December 1999)

Lacrimal gland CD5-positive, primary, extra-nodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT) – Type Kaustubh Mulay, DNB, Santosh.

A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma.

It's time to bring the best and brightest back to gastroenterology!

Helicobacter pylori infection and gastric carcinoma

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Metronidazole susceptibility in Helicobacter pylori

Effect of Eradication of Helicobacter pylori on the Histology and Cellular Phenotype of Gastric Intestinal Metaplasia Jiro Watari, Koushik K. Das, Peter.

Volume 119, Issue 5, Pages (November 2000)

Visualization of Lymphoepithelial Lesions in Gastric Mucosa-Associated Lymphoid Tissue–Type Lymphoma by Miniprobe Confocal Laser Microscopy Andrea Morgner,

Helicobacter pylori Mayo Clinic Proceedings

Helicobacter pylori infection and gastric carcinoma

Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report Philip V. Hassard, Scott W. Binder, Viera.

Diagnosis of irritable bowel syndrome

Volume 119, Issue 3, Pages (September 2000)

Gastric cancer, cytotoxin-associated gene A–positive Helicobacter pylori, and serum pepsinogens: An international study Penelope M. Webb, Jean E. Crabtree,

Diagnosing Helicobacter pylori In Vivo by Confocal Laser Endoscopy

Covering the Cover Gastroenterology

Volume 118, Issue 5, Pages (May 2000)

Volume 124, Issue 4, Pages (April 2003)

PPI-based triple therapy in the eradication of H. pylori infection

Amnon Sonnenberg, Richard H. Lash, Robert M. Genta Gastroenterology

Volume 119, Issue 5, Pages (November 2000)

Metronidazole susceptibility in Helicobacter pylori

Volume 115, Issue 5, Pages (November 1998)

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families Paul D.P. Pharoah,

Volume 143, Issue 4, Pages (October 2012)

Volume 123, Issue 2, Pages (August 2002)

Digital metastasis of tongue squamous cell carcinoma

Volume 119, Issue 1, Pages 7-14 (July 2000)

Judy A. Trieu, Mohammad Bilal, Ali Hashmi

Pancreatic involvement in von Hippel–Lindau disease

Gastric intestinal metaplasia on routine endoscopic biopsy

Volume 117, Issue 1, Pages (July 1999)

Lip edema Journal of the American Academy of Dermatology

Volume 120, Issue 4, Pages (March 2001)

Severe Constipation Clinical Gastroenterology and Hepatology

Management strategies for dysphagia with a normal-appearing esophagus

Eugene B. Chang Gastroenterology Volume 124, Issue 4, (April 2003)

Volume 121, Issue 4, Pages (October 2001)

Volume 120, Issue 4, Pages (March 2001)

A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques Joseph J. Mattapallil, Satya.

Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud

AGA technical review on nonalcoholic fatty liver disease

Brennan M.R. Spiegel, Nimish B. Vakil, Joshua J. Ofman

Volume 117, Issue 6, Pages (December 1999)

Regression of MALT lymphoma of the rectum after anti–H

AGA technical review on celiac sprue

A patient with improvement of ulcerative colitis after appendectomy

Image of the month Gastroenterology

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Histological outcome during long-term lamivudine therapy

Volume 121, Issue 5, Pages (November 2001)

Volume 114, Issue 4, Pages (April 1998)

Volume 116, Issue 5, Pages (May 1999)

Volume 123, Issue 4, Pages (October 2002)

AGA technical review on osteoporosis in gastrointestinal diseases

Vincenzo Mazzaferro, Andrea Pulvirenti, Jorgelina Coppa

Olga Vornicova, MD, Gil Bar-Sela, MD JAAD Case Reports

James E. Graham, Richard M. Peek, Uma Krishna, Timothy L. Cover

Eradication Therapy for Helicobacter pylori

Marcia Irene Canto, MD, MHS Gastrointestinal Endoscopy

Volume 123, Issue 1, Pages (July 2002)

Volume 163, Issue 2, (October 2015)

Volume 120, Issue 4, Pages (March 2001)

Kimitoshi Kato, MD Gastrointestinal Endoscopy

Presentation transcript:

First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori Stephan Timm, Marco Sailer, Karl–hermann Fuchs, Axel Greiner Gastroenterology Volume 121, Issue 4, Pages 1025-1026 (October 2001) DOI: 10.1053/gast.2001.28579 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 1 (A) Diffuse large B-cell lymphoma in the patient's first biopsy specimen (H&E stain, 250×). The arrow indicates a lymphoepithelial lesion characteristic for MALT-type lymphoma. (B) Twelve weeks after eradication biopsy without histologic evidence of lymphoma with “empty-appearing” mucosa because of destroyed glands (H&E stain, 25×). Gastroenterology 2001 121, 1025-1026DOI: (10.1053/gast.2001.28579) Copyright © 2001 American Gastroenterological Association Terms and Conditions